AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss  by Hsieh, Helen et al.
Neuron 52, 831–843, December 7, 2006 ª2006 Elsevier Inc. DOI 10.1016/j.neuron.2006.10.035AMPAR Removal Underlies Ab-Induced
Synaptic Depression and Dendritic Spine LossHelen Hsieh,1,2 Jannic Boehm,1 Chihiro Sato,3
Takeshi Iwatsubo,3 Taisuke Tomita,3
Sangram Sisodia,4 and Roberto Malinow1,2,*
1Cold Spring Harbor Laboratory
Cold Spring Harbor, New York 11724
2Department of Neurobiology and
Behavior Graduate Program
State University of New York at Stony Brook
Stony Brook, New York 11794
3Department of Neuropathology and Neuroscience
Graduate School of Pharmaceutical Sciences
University of Tokyo
Tokyo
Japan
4Center for Molecular Neurobiology
Department of Neurobiology, Pharmacology,
and Physiology
The University of Chicago
Chicago, Illinois 60637
Summary
Beta amyloid (Ab), a peptide generated from the amy-
loid precursor protein (APP) by neurons, is widely be-
lieved to underlie the pathophysiology of Alzheimer’s
disease. Recent studies indicate that this peptide can
drive loss of surface AMPA and NMDA type glutamate
receptors. We now show that Ab employs signaling
pathways of long-term depression (LTD) to drive endo-
cytosis of synaptic AMPA receptors. Synaptic removal
of AMPA receptors is necessary and sufficient to
produce loss of dendritic spines and synaptic NMDA
responses. Our studies indicate the central role played
by AMPA receptor trafficking in Ab-induced modifica-
tion of synaptic structure and function.
Introduction
Alzheimer’s disease (AD), a progressive neurodegenera-
tive disorder, is characterized by early deficits in learn-
ing and memory with eventual loss of higher cognitive
functions (Selkoe and Schenk, 2003). Brains from AD
patients reveal intracellular neurofibrillary tangles com-
posed of hyperphosphorylated tau protein and Ab-rich
plaques. Evidence from human genetics and transgenic
mouse studies has supported a role for Ab in the etiology
and pathogenesis of AD (Selkoe and Schenk, 2003).
Memory deficits in AD patients, however, do not corre-
late well with Ab plaque burden, but rather loss of synap-
tic markers is a strong predictor for clinical symptoms
and disease progression. Recent studies have sug-
gested that Ab is a homeostatic regulator of synaptic
strength (Kamenetz et al., 2003). These data have lent
support to the notion that perturbations in soluble Ab
levels, and their effects on synapses, might be directly
linked to the learning and memory deficits in patients
*Correspondence: malinow@cshl.orgwith AD (Carter et al., 2004; Lue et al., 1999; Masliah
et al., 2001; Terry et al., 1991).
Excitatory synapses contain AMPA and NMDA iono-
tropic glutamate receptors as well as metabotropic
type glutamate receptors (mGluRs) positioned on den-
dritic spines (Baude et al., 1993; Takumi et al., 1999).
Basal transmission is largely mediated by AMPA recep-
tors. Brief periods of high synaptic activity open NMDA
receptors, leading to a long-lasting increase in postsyn-
aptic AMPA receptor number, spine growth, and long-
term potentiation (LTP) of synaptic transmission (Bliss
and Lomo, 1973). Alternatively, low levels of synaptic
stimulation can activate NMDA receptors to produce
NMDA-dependent long-term depression (LTD) or
mGluRs to produce mGluR-dependent LTD. These two
forms of LTD can induce removal of postsynaptic
AMPA receptors and loss of spines (Lee et al., 2002;
Luscher et al., 1999; Man et al., 2000; Nagerl et al.,
2004; Snyder et al., 2001; Xiao et al., 2001; Zhou et al.,
2004). It is generally believed that plasticity, such as
LTP and LTD, are important processes for learning and
memory. Multiple signaling pathways, which include
several protein kinases and phosphatases, are required
for the generation of LTP and LTD (Sheng and Kim,
2002). These same pathways have been shown to influ-
ence in vivo phenomena, such as learning and memory
(Rodrigues et al., 2004).
Studies from AD mouse models have lent further sup-
port to the hypothesis that Ab causes ‘‘synaptic failure’’
before plaques develop and neuron death occurs
(Selkoe, 2002). Neurons from transgenic APP mice that
express genes encoding mutant APP or presenilin linked
to familial, autosomal-dominant forms of AD (FAD) ex-
hibit decreased synaptophysin and PSD95 staining as
well as dendritic spine loss (Almeida et al., 2005; Hsia
et al., 1999; Lanz et al., 2003; Mucke et al., 2000; Spires
et al., 2005). These mice develop mature amyloid pla-
ques, are impaired on learning tasks, and can show def-
icits in LTP (Billings et al., 2005; Chapman et al., 1999;
Giacchino et al., 2000; Larson et al., 1999; Moechars
et al., 1999; Oddo et al., 2003; Stern et al., 2004). Further-
more, application of Ab, in vivo and in vitro, adversely af-
fects LTP and synaptic transmission (Cleary et al., 2005;
Cullen et al., 1997; Freir et al., 2001; Walsh et al., 2002).
Interestingly, learning and synaptic dysfunction appear
before the formation of plaques, suggesting that a phys-
iological deficit rather than a loss of neurons underlies
the initial development of the disease (Hsia et al., 1999;
Kamenetz et al., 2003; Mucke et al., 2000; Oddo et al.,
2003). Studies from our laboratory, and others, have
shown that elevated Ab levels result in depressed gluta-
matergic synaptic transmission and glutamate receptor
endocytosis (Almeida et al., 2005; Hsia et al., 1999;
Kamenetz et al., 2003; Oddo et al., 2003; Roselli et al.,
2005; Snyder et al., 2005).
In this manuscript, we examine the mechanisms un-
derlying Ab-mediated synaptic depression. We find sev-
eral parallels between LTD and Ab-induced synaptic
changes. Ab overexpression decreases spine density,
partially occludes mGluR-dependent LTD, decreases
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messenger pathways implicated in LTD for its depres-
sive effects. Expression of an AMPAR mutant that
prevents its LTD-driven endocytosis blocks the mor-
phological and synaptic depression induced by Ab. Fur-
thermore, Ab can drive phosphorylation of AMPARs at
a site important for AMPAR endocytosis during LTD,
and mimicking this AMPAR phosphorylation produces
the morphological and synaptic depression induced by
Ab. Taken together, these results show that Ab gener-
ates structural and synaptic abnormalities via endocyto-
sis of AMPA receptors.
Results
Increased Ab Levels Reduce Pyramidal Neuron
Spine Density
To examine the effects of increased Ab levels on den-
dritic spine structure, we imaged CA1 pyramidal neu-
rons in organotypic slice cultures transfected with
cDNA encoding APP and, as a cytoplasmic marker,
EGFP, with two-photon laser scanning microscopy
(2PLSM) (Figure 1A). A point mutant of APP, APP(MV),
was used as a control construct since this APP mutant
is cleaved by a-secretase, but not by b-secretase
(BACE), thus APP(MV) cannot produce Ab (Citron et al.,
1994). Furthermore, overexpression of APP(MV) does
not affect glutamatergic synaptic transmission, while
APP overexpression depresses glutamatergic synaptic
transmission (Kamenetz et al., 2003) (Figure 1E). Indeed,
Ab production from APP and its release is necessary and
sufficient to induce this synaptic depression (Kamenetz
et al., 2003). Thus, differences on synaptic structure and
function observed between the effects of overexpress-
ing APP or APP(MV) should be attributable to increased
levels of Ab.
Three days after transfection, spine density in APP-
expressing cells was decreased by 31% when com-
pared to control APP(MV)-expressing cells or by 36%
when compared to cells expressing EGFP alone (Figures
1A and 1C). To confirm that Ab is the causative agent
that reduces spine density, we transfected slice cultures
with EGFP and then incubated them with either syn-
thetic Ab(1-42), reverse Ab(42-1), or vehicle for 7 days.
EGFP-labeled neurons exposed to Ab(1-42) had lower
spine density when compared to neurons exposed to
reverse Ab(42-1) or vehicle (Figures 1B and 1D). These
results indicate that Ab overexpressed by neurons or
exogenously applied causes a loss of dendritic spines.
Ab-Induced Synaptic Depression Partially Occludes
mGluR LTD
Ab depresses excitatory glutamatergic synaptic trans-
mission and induces spine loss; findings that are also
observed in LTD (Nagerl et al., 2004; Zhou et al., 2004).
To determine whether LTD and Ab-mediated synaptic
depression use common mechanisms, we performed
an occlusion experiment (Figure 2). We examined the ef-
fect of LTD induction on a control cell and a cell in which
synaptic transmission is depressed by Ab production.
To drive Ab production, we expressed b-CTF, the
BACE1-generated transmembrane product of APP that
is the penultimate precursor of Ab. We expressed
b-CTF rather than APP to avoid complications with theFigure 1. Ab Reduces Spine Density
(A) CA1 pyramidal cells cotransfected with EGFP and either APP or
APP(MV) imaged with two-photon laser scanning microscopy
(2PLSM). Scale: 10 mm.
(B) CA1 pyramidal cells transfected with EGFP and incubated for
7 days in either vehicle (0.2% DMSO, 0.5 mM Tris), Ab(1-42) (1 mM),
or Ab(42-1) (1 mM).
(C) Overexpression of Ab decreases spine density (spine density
(sp/mm): EGFP: 0.7 6 0.03, 53 dendrites, 5 cells; APP: 0.4 6 0.02,
106 dendrites, 10 cells, p < 0.01; APP(MV): 0.66 0.02, 114 dendrites,
10 cells, p = 0.2; APP versus APP(MV), p < 0.01).
(D) Ab(1-42) incubation for 7 days decreases spine density (spine
density (sp/mm): control vehicle and Ab(42-1) combined: 0.8 6
0.04, 66 dendrites, 8 cells, Ab(1-42): 0.66 0.05, 24 dendrites, 4 cells,
p < 0.01).
(E) Ab overexpression depresses glutamatergic synaptic transmis-
sion (normalized to control (pA): AMPA: control: 1 6 0.07(40 6 3),
APP: 0.6 6 0.08(23 6 3), n = 13, p < 0.01; NMDA: control: 1 6
0.2(326 8), APP: 0.56 0.2(176 5), n = 11, p < 0.01), while EGFP alone
(AMPA: control: 1 6 0.15(33 6 5), EGFP: 1.3 6 0.1(42 6 5), n = 14
pairs, p = 0.4; NMDA: control: 1 6 0.20(24.3 6 4.8), EGFP: 13 6
0.29(24.9 6 7.0), n = 12, p = 0.4) or with APP(MV) do not depress
transmission (AMPA: control: 1 6 0.1(31 6 2), APP(MV): 1 6
0.1(296 3), n = 20, p = 0.6; NMDA: control: 16 0.3(126 3); APP(MV):
1.16 0.4(136 5), n = 14, p = 0.7). Scale: 20 pA, 20 ms. p values from
t test (spine density) and Wilcoxon test (EPSC). All data here and
below are reported as mean 6 standard error of the mean (SEM)
and **p < 0.01, *p < 0.05.
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833Figure 2. Ab-Induced Synaptic Depression
Partially Mimics and Occludes mGluR Long-
Term Depression
(A) Normalized EPSC amplitudes plotted
against time from pairs of uninfected (B)
and b-CTF (A) infected CA1 pyramidal neu-
rons during baseline and after LTD induction
(100 mM DHPG, 5 min). Baseline and 35–40
min data are summarized on the right. Base-
line AMPA currents (normalized to control
(pA): 1 6 0.08(82.7 6 7.0), b-CTF: 0.6 6
0.1(53 6 10), n = 14, p < 0.01). After DHPG
(normalized to control baseline (pA): control:
0.3 6 0.04(22 6 3), b-CTF: 0.3 6 0.1(20 6 2),
n = 9, p = 0.6). Scale: 10 pA, 20 ms.
(B) Ab-induced depression of NMDA currents
occludes mGluR-dependent LTD. Without
DHPG (AMPA: control: 1 6 0.2(44 6 6), b-
CTF: 0.5 6 0.1 (22 6 4), n = 16, p < 0.01;
NMDA: control: 1 6 0.1(29 6 3), b-CTF:
0.8 6 0.1(23 6 3), n = 15, p < 0.01). After 5
min of 100 mM DHPG (AMPA: control: 1 6
0.1(26 6 4), b-CTF: 1.1 6 0.2(29 6 5), n = 17,
p = 0.8; NMDA: control 1 6 0.3(5 6 2), b-
CTF: 1.3 6 0.3(7 6 2), n = 16, p = 0.2).
(C) APLP2/APP construct does not affect
mGluR LTD induction (AMPA: control: 1 6
0.1(47 6 6), APLP2/APP: 0.9 6 0.1(41 6 5),
n = 17, p = 0.3; NMDA: control: 1 6 0.2(25 6
4), APLP2/APP: 0.9 6 0.1(22 6 3), n = 13,
p = 0.08) and after 5 min of 100 mM DHPG
(AMPA: control: 1 6 0.2(37 6 6), APLP2/
APP: 0.9 6 0.1(34 6 5), n = 13, p = 0.3;
NMDA: control: 1 6 0.3(36 6 9), APLP2/
APP: 1.1 6 0.30(39 6 11), n = 12, p = 0.8). All
p values from Wilcoxon test. Scale: 20 pA,
20 ms.
Error bars indicate SEM.activity-dependent nature of Ab production from APP,
which is circumvented by b-CTF (Cirrito et al., 2005; Ka-
menetz et al., 2003). After expressing b-CTF for 22–26 hr
in hippocampal CA1 pyramidal cells, which depressed
glutamatergic synaptic transmission, we examined the
magnitude of mGluR-dependent LTD induced in control
and infected neurons with bath application of DHPG
(100 mM, 5 min), a mGluR group I agonist (Huber et al.,
2001; Palmer et al., 1997). During baseline (before
DHPG), b-CTF-expressing neurons showed 34% de-
pression of evoked AMPAR transmission relative to un-
infected cells (Figure 2A). After DHPG application, no
significant difference in evoked synaptic transmission
was observed between b-CTF and control cells (29.4%
versus 28.5% of control baseline). Both control and b-
CTF-overexpressing cells displayed significant mGluR
LTD, but the magnitude of mGluR LTD induced in the
control cells was greater (control, 70% depression; in-
fected, 50%). To control for the possibility that expres-
sion of a transmembrane protein could affect LTD, we
conducted similar experiments with a b-CTF chimera
(APLP2/APP) where the Ab domain is replaced with the
corresponding region in the amyloid precursor-like pro-
tein 2 (APLP2). APLP2 belongs to the APP family of pro-
teins and shows considerable homology to APP except
at the Ab region (Wasco et al., 1993). Expression of
APLP2/APP did not depress synaptic transmission (as
expected since no Ab is formed) nor did it affect mGluR
LTD induction (three cell pairs, data not shown). Impor-tantly, evoked synaptic currents were not different
between infected and noninfected cells, either before
or after LTD induction (Figure 2C). These results indicate
that Ab induces synaptic depression that partially oc-
cludes and potentially shares mechanisms with mGluR
LTD.
To examine whether Ab depression of NMDAR synap-
tic transmission also occludes mGluR LTD of NMDAR
responses, we recorded excitatory postsynaptic cur-
rents (EPSCs) from pairs of control and b-CTF-infected
cells after DHPG application. NMDAR EPSCs measured
in cells expressing b-CTF were not significantly different
from controls (Figure 2B). Therefore, Ab-induced synap-
tic depression partially mimics and occludes mGluR
LTD of both AMPA- and NMDAR synaptic transmission.
p38 MAP Kinase and Calcineurin Are Required
for Ab-Induced Synaptic Depression
The occlusion experiments suggest that Ab-induced
synaptic depression and LTD share similar signaling
mechanisms. We thus examined whether second mes-
sengers required for LTD also participate in Ab-induced
synaptic depression. p38 mitogen-activated protein
kinase (MAPK) is required for, and is activated by, LTD
(Bolshakov et al., 2000; Huang et al., 2004; Rush et al.,
2002). Calcineurin (protein phosphatase 2B) is also
required for LTD (Mulkey et al., 1994).
To test whether p38 MAPK and calcineurin are
also required for Ab-mediated synaptic depression,
Neuron
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Requires p38 MAPK and Calcineurin Activity
(A) AMPA and NMDA EPSCs recorded from
pairs of noninfected or APP-infected CA1 py-
ramidal neurons. Slices maintained in culture
with vehicle (normalized to control (pA):
AMPA: control: 1 6 0.1(42 6 3), APP: 0.6 6
0.1(27 6 2), n = 22, p < 0.01; NMDA: control:
16 0.1(426 6), APP: 0.66 0.1(276 5), n = 19,
p < 0.01), p38 MAPK inhibitor, SB203580
(2 mM) (AMPA: control: 1 6 0.1(37 6 3), APP:
0.96 0.1(336 3), n = 19, p = 0.14; NMDA: con-
trol: 16 0.1(166 2), APP: 126 0.2(166 3), n =
19, p = 0.9), calcineurin inhibitor, FK506
(50 mM) (AMPA: control: 1 6 0.2(37 6 6),
APP: 1.2 6 0.1 (45 6 4) n = 9, p = 0.2;
NMDA: control: 1 6 0.1 (25 6 3), APP: 1 6
0.2(25 6 5), n = 9, p = 0.95) or JNK inhibitor,
SP600125 (5 mM) (AMPA: control: 1 6
0.2(58 6 12), APP: 0.5 6 0.1(30 6 5), n = 11,
p = 0.01; NMDA: control: 1 6 0.2(48 6 8),
APP: 0.6 6 0.1 (31 6 6), n = 11, p < 0.01).
p values from Wilcoxon test. Scale: 20 pA,
20 ms.
(B) Results with cells expressing b-CTF (vehi-
cle: AMPA: control: 1 6 0.2(44 6 6), b-CTF:
0.5 6 0.1 (22 6 4), n = 16, p < 0.01; NMDA:
control: 1 6 0.1 (29 6 3), b-CTF: 0.78 6
0.1(23 6 3), n = 15, p < 0.01; SB203580:
AMPA: control: 1 6 0.14(29 6 4), b-CTF:
0.96 0.2(286 5), n = 16, p = 0.4; NMDA: con-
trol: 16 0.1 (11 6 6), b-CTF: 156 0.2(116 2),
n = 15, p = 0.6, FK506: AMPA: control: 1 6
0.2(32 6 6), b-CTF: 11 6 0.1(33 6 5), n = 11,
p = 0.6; NMDA: control: 1 6 0.3(23 6 7),
b-CTF: 1 6 0.2(23 6 5), n = 10, p = 0.8).
p values from Wilcoxon test. Scale: 20 pA,
20 ms.
(C and D) Incubation of transgenic APPSwe
mouse hippocampal slices with p38 MAPK
inhibitor (SB203580) does not affect Ab40 or
Ab42 secretion (in pM: vehicle: Ab40:
2900 6 160, Ab42: 190 6 13; SB203580:
Ab40: 3100 6 100, p = 0.2, Ab42: 200 6 9,
p = 0.3, n = 4 for each condition), while calci-
neurin/PP2B inhibitor (FK506) slightly de-
creases Ab40 and increases Ab42 secretion
(in pM: vehicle: Ab40: 3300 6 200, Ab42:
160 6 10; FK506: Ab40: 2600 6 200, p =
0.04, Ab42: 290 6 20, p < 0.01, n = 9 for
each condition). A g-secretase inhibitor
(L-685,458, 2 mM) decreases Ab40 levels (in
pM: for SB203580 trial: Ab40: 1800 6 130,
p < 0.01, Ab42: 180 6 6, p = 0.2; for FK506 trial: Ab40: 2000 6 200, p < 0.001, Ab42: 180 6 9, p = 0.5). p values from t test.
(E) Sample traces of mEPSCs recorded in vehicle, p38 MAPK inhibitor (SB203580), and calcineurin/PP2B inhibitor (FK506). Scale: 20 pA, 0.25 s.
(F and G) p38 MAPK inhibitor (SB203580) increases mEPSC frequency, while calcineurin/PP2B inhibitor (FK506) increases mEPSC frequency
and amplitude (frequency (Hz): vehicle: 0.2 6 0.02, n = 16, SB203580: 0.3 6 0.03, n = 16, p = 0.01, FK506: 0.3 6 0.03, n = 16, p < 0.01) (mEPSC
amplitude (pA): vehicle: 14 6 0.5, n = 16, SB203580: 16 6 0.7, n = 16, p = 0.07, FK506: 17 6 1, n = 16, p < 0.01). p values from t test.
Error bars indicate SEM.APP-infected slices were incubated with inhibitors of
p38 MAPK (SB203580, 2 mM) or calcineurin (FK506,
50 mM). Whole-cell recordings were obtained from
nearby infected and noninfected cells. Slices main-
tained in SB203580 or FK506 exhibited no depressed
transmission in infected cells when compared to nonin-
fected cells (Figure 3A). Since SB203580 also blocks
JNK, we tested the JNK inhibitor, SP600125, to ensure
that SB203580’s effects were specific to the p38
MAPK pathway (Whitmarsh et al., 1997). SP600125 did
not block Ab-mediated synaptic depression (Figure 3A).To ensure that these drugs did not affect BACE1-depen-
dent Ab production, we tested the effect of these com-
pounds on b-CTF-infected cells. The p38 MAPK and
calcineurin inhibitors also blocked synaptic depression
induced by b-CTF (Figure 3B), similar to cells expressing
full-length APP. To further rule out effects on Ab secre-
tion, secreted Ab was measured from slice cultures
made from transgenic mice expressing APP with the
familial Swedish mutation (Borchelt et al., 1997) and
incubated with p38 MAPK and calcineurin inhibitors.
p38 MAPK inhibitor had no effect on either Ab40 or
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GluR1
(A) 2PLSM images of neurons coexpressing
GluR2 tagged with Super-ecliptic pHluorin
(SEP-GluR2), T1dimer, and APP or APP(MV).
Note reduced surface SEP-GluR2 in cells ex-
pressing APP. Scale: 1 mm.
(B) 2PLSM images of neurons coexpressing
GluR1 tagged with Super-ecliptic pHluorin
(SEP-GluR1), T1dimer, and APP or APP(MV).
Note reduced surface SEP-GluR1 in cells ex-
pressing APP. Scale: 1 mm.
(C) The surface SEP-GluR2 (green signal)
normalized by volume (red signal) (Green/
Normalized Red) in spines and dendrites is
decreased in APP coexpressing neurons
compared to SEP-GluR2 expression alone
or with APP(MV) (spines: SEP-GluR2:
46000 6 930, n = 1046 spines, APP/SEP-
GluR2: 170006 400, n = 482 spines, compare
to SEP-GluR2: p < 0.01; dendrite: SEP-GluR2:
14800 6 460, n = 1046 boxes, 4 cells, APP/
SEP-GluR2: 44006 160, n = 482 boxes, com-
pare to SEP-GluR2: p < 0.01, 5 cells; APP(MV)/SEP-GluR2: spines: 37000 6 1500, n = 554 spines, compare to APP/SEP-GluR2: p < 0.01, den-
drites: 14000 6 700, n = 554 boxes, compare to APP/SEP-GluR2: p < 0.01, 5 cells).
(D) The surface SEP-GluR1 normalized by volume (Green/Normalized Red) in spines and dendrites is decreased in APP coexpressing neurons
compared to SEP-GluR1 expression alone or with APP(MV) (spines: SEP-GluR1: 377006 1000, n = 512 spines, APP/SEP-GluR1: 270006 1200,
n = 315 spines, compare to SEP-GluR1: p < 0.01; dendrite: SEP-GluR1: 140006 700, n = 512 boxes, 4 cells, APP/SEP-GluR1: 110006 500, n = 315
boxes, compare to SEP-GluR1: p < 0.01, 5 cells; APP(MV)/SEP-GluR1: spines: 35000 6 1100, n = 505 spines, compare to APP/SEP-GluR1:
p < 0.01, dendrites: 16000 6 790, n = 505 boxes, compare to APP/SEP-GluR1: p < 0.01). p values from t test.
Error bars indicate SEM.Ab42 secretion, while calcineurin inhibitor slightly de-
creased Ab40 and increased Ab42 secretion (Figures
3C and 3D). As a positive control, the g-secretase inhib-
itor L685,458 reduced Ab40 secretion by about 50%
(Figures 3C and 3D). To rule out the possibility that these
drugs mimicked and occluded (rather than blocked) Ab-
induced depression, we tested their effects on basal
synaptic transmission by monitoring their effects on
spontaneous miniature events (minis). Slices incubated
for 24 hr in p38 MAPK or calcineurin inhibitors showed
no decrease in mini amplitude or frequency when com-
pared to vehicle (DMSO), indicating that these drugs did
not depress synaptic transmission (Figures 3E–3G).
Indeed, transmission in slices maintained in these drugs
was significantly elevated, consistent with the view that
slices maintained in normal media undergo some level
of an LTD-like process in basal conditions (Zhu et al.,
2002). These results indicate that Ab-induced synaptic
depression shares second messenger pathways with
LTD.
Increased Ab Levels Cause a Decrease in Surface
and Synaptic AMPARs
LTD removes surface and synaptic glutamate receptors
(Beattie et al., 2000; Lee et al., 2002; Luscher et al., 1999;
Luthi et al., 1999). Furthermore, application of synthetic
Ab results in surface removal of NMDA and GluR1 recep-
tors in dissociated cultured hippocampal neurons
(Almeida et al., 2005; Snyder et al., 2005). We tested
whether Ab removes surface and synaptic AMPARs in
organotypic slices, a model system that approximates
trafficking of glutamate receptors in vivo better (i.e., fol-
lowing recombinant expression, GluR1 appears consti-
tutively at synapses in dissociated cultured neurons
[Passafaro et al., 2001; Shi et al., 2001], while it requires
plasticity-inducing activity to reach synapses in organo-typic slices or in vivo [Rumpel et al., 2005; Shi et al.,
2001]).
To examine surface AMPARs, we coexpressed APP
[or APP(MV) as a control] together with an AMPAR sub-
unit tagged on its N terminus with Super ecliptic
pHluorin (SEP) (Figures 4A and 4B). SEP is a pH-sensi-
tive GFP variant that exhibits a nearly 30-fold decrease
in fluorescence when it translocates from a neutral
(i.e., cell surface) to an acidic environment (i.e., endo-
cytic compartments) and thus is a useful surface marker
for transmembrane proteins that undergo recycling and/
or endocytosis (Ashby et al., 2004; Kopec et al., 2006;
Miesenbock et al., 1998). A third construct, encoding
tDimer dsRed, was coexpressed as a cytoplasmic
marker. The ratio of green (SEP) to red (tDimer dsRed)
signal normalized for soma red signal is a volume-nor-
malized measure of surface receptor (see Experimental
Procedures for normalization measure). APP coexpres-
sion significantly reduced this normalized green-to-red
ratio in spines and dendrites compared to APP(MV)- or
SEP-tagged receptor alone for both GluR1 and GluR2
subunits (Figure 4). This effect is not due to differences
in AMPAR expression, since AMPAR expression was
not different among the various groups as measured in
the cell body (see Figure S1 in the Supplemental Data
available online). We conclude that surface AMPARs
on spines and dendrites are reduced by APP over-
expression (Figures 4C and 4D). Since this effect was
significantly greater in cells expressing APP than those
expressing APP(MV), we conclude that Ab leads to
a loss of spine and dendritic surface AMPA receptors.
While reduced surface receptor expression on spines
is suggestive, it does not necessarily translate into
synaptic depression. Surface receptors can be extra-
synaptic and may not contribute to evoked currents
(Borgdorff and Choquet, 2002; Schnell et al., 2002). To
Neuron
836Figure 5. Ab Overexpression Decreases Synaptic GluR2 and
Depresses Synaptic Transmission; GluR2(R845A) Blocks the Ab-
Induced Decrease in Synaptic GluR2 and Transmission
(A) The GluR2(R607Q) mutant increases rectification (normalized to
control: 16 0.12, GluR2(R607Q): 2.26 0.3, n = 12, p < 0.01), which is
not different from APP(MV)/GluR2(R607Q) expressing neuronsmonitor synaptic receptors, we used an ‘‘electrophysio-
logically tagged’’ GluR2 mutant, GluR2(R607Q), which
was also tagged with an N-terminal GFP to allow identi-
fication of transfected neurons (Shi et al., 2001). This
mutant, when overexpressed, forms inwardly rectifying
homomeric receptors that replace endogenous synaptic
receptors in a constitutive manner without affecting
basal synaptic transmission or plasticity (Seidenman
et al., 2003; Shi et al., 2001) (Figure 5B). Neurons ex-
pressing the receptor alone, or with the control APP(MV)
construct, exhibit significantly increased rectification of
AMPAR-mediated synaptic currents, indicating incor-
poration of the recombinant AMPAR into synapses
(Figure 5A). When APP is coexpressed, however, there
is a significant decrease in rectification when compared
to the rectification measured in cells expressing
GluR2(R607Q) alone or coexpressing APP(MV) (Fig-
ure 5A). In agreement with our previous data (Kamenetz
et al., 2003) (Figure 1E), coexpression of APP with
(control: 1 6 0.04, APP(MV)/GluR2(R607Q): 2 6 0.2, n = 18, p <
0.01; compare to GluR2(R607Q): p = 0.9). APP coexpression with
GluR2(R607Q) decreases rectification (control: 1 6 0.06, APP/
GluR2(R607Q): 1.56 0.1, n = 20, p < 0.01; compare to GluR2(R607Q):
p = 0.035; compare to APP(MV)/GluR2(R607Q): p < 0.05). Overex-
pression of GluR2(R607Q;R845A) results in slightly increased recti-
fication (control: 1 6 0.05, GluR2(R607Q;R845A): 2.8 6 0.3, n = 13,
p < 0.01). Rectification of cells coexpressing GluR2(R607Q;R845A)
with APP or APP(MV) is not statistically different from cells express-
ing receptor alone (control: 1 6 0.05, APP/GluR2(R607Q;R845A):
3.2 6 0.3, n = 13, p < 0.01, compare to GluR2(R607Q;R856A), p =
0.4, compare to APP(MV)/GluR2(R607Q;R845A), p = 0.6) (control:
1 6 0.2, APP(MV)/GluR2(R607Q;R845A): 3 6 0.3, n = 15, p < 0.01,
compare to GluR2(R607Q;R845A), p = 0.8). p values from t test.
(B) AMPA and NMDA EPSCs recorded simultaneously from pairs of
untransfected and transfected neurons. Overexpression of
GluR2(R607Q) alone or with APP(MV) does not affect synaptic trans-
mission. (Normalized to control(pA): AMPA: control: 1 6 0.2(33.2 6
6.5), GluR2(R607Q): 136 0.13(346 4), n = 10, p = 0.6; NMDA: control:
1 6 0.3(23 6 6), GluR2(R607Q): 0.8 6 0.2(19 6 4), n = 9, p =
0.8)(AMPA: control: 1 6 0.10(40 6 4), APP(MV)/GluR2(R607Q):
1.2 6 0.1(47 6 4), n = 24, p = 0.6; NMDA: control: 1 6 0.18(30 6 5),
APP(MV)/GluR2(R607Q): 0.86 0.2(266 5), n = 14, p = 0.06). APP co-
expression with GluR2(R607Q) depresses synaptic transmission
(AMPA: control: 1 6 0.06(49 6 3), APP/GluR2(R607Q): 0.6 6
0.05(31 6 3), n = 26, p < 0.01; NMDA: control: 1 6 0.2(19 6 4),
APP/GluR2(R607Q): 0.6 6 0.1(11 6 2), n = 13, p < 0.01).
GluR2(R607Q;R845A) expression alone potentiates AMPA, while
not affecting NMDA EPSCs (AMPA: control: 1 6 0.10(38 6 4),
GluR2(R607Q;R845A): 1.3 6 0.1 (51 6 5), n = 24, p < 0.01; NMDA:
control: 1 6 0.2(30 6 5), GluR2(R607Q;R845A): 1 6 0.2(28 6 5), n =
13, p = 0.4). Coexpression with APP or APP(MV) does not signifi-
cantly change synaptic transmission when compared to receptor
alone (AMPA: control: 1 6 0.1(36 6 3), APP/GluR2(R607Q;R845A):
1.4 6 0.1(50 6 4), n = 28, p = 0.01; NMDA: control: 1 6 0.2(28 6 4),
APP/GluR2(R607Q;R845A): 0.9 6 0.1(25 6 2), n = 14, p = 0.8)
(AMPA: control: 1 6 0.1(38 6 3), APP(MV)/GluR2(R607Q;R845A):
1.3 6 0.1 (48 6 4), n = 21, p = 0.03; NMDA: control: 1 6 0.4(15 6
5), APP(MV)/GluR2(R607Q;R845A): 0.9 6 0.3(13 6 4), n = 6, p = 0.5).
(C) Ab application reduces synaptic GluR2(R607Q). Hippocampal
CA1 neurons were infected with GluR2(R607Q) and slices subse-
quently treated with 2 mM Ab(1-42) or Ab(42-1). Rectification was
measured from neighboring infected and noninfected cells. (Nor-
malized rectification: Ab(42-1): control: 1 6 0.1, GluR2(R607Q):
1.4 6 0.1; Ab(1-42): control: 1 6 0.1, GluR2(R607Q): 19 6 0.1; each
n = 10; p < 0.05).
p values calculated with Wilcoxon test. Scale: 20 pA, 20 ms. Error
bars indicate SEM.
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mediated synaptic transmission, while APP(MV) co-
expression does not (Figure 5B). APP overexpression
did not affect the expression level of recombinant
GluR2(R607Q) nor did it affect endogenous levels of
GluR2 or GluR1 (see Figure S1). To confirm that Ab is
responsible for the effects of APP overexpression on
synaptic removal of AMPA receptors, we exposed slices
expressing GluR2(R607Q) to 2 mM Ab(1-42) peptide or
reverse Ab(42-1) for 36 hr. In slices exposed to control
(reverse) peptide, neurons expressing GluR2(R607Q)
showed significantly increased rectification compared
to neurons not expressing GluR2(R607Q), indicating
Figure 6. Expression of S880E Mutant of GluR2, which Drives
Synaptic AMPA Receptor Endocytosis, Results in Depressed
AMPA- and NMDA-Mediated Currents and Spine Loss
(A) Apical dendrites expressing GluR2(R607Q) or
GluR2(R607Q;S880E). Scale: 10 mm.
(B) Overexpression of GluR2(R607Q;S880E) results in a decrease in
spine density (GluR2(R607Q) (spines/mm): 0.786 0.03, 43 dendrites,
6 cells, GluR2(R607Q;S880E): 0.66 6 0.03, n = 63 dendrites, 6 cells,
p = 0.01). p value calculated with t test.
(C) Overexpression of GluR2(R607Q;S880E) depresses AMPA and
NMDA EPSCs (normalized to control (pA): AMPA: control: 1 6 0.1
(47 6 5), GluR2(R607Q;S880E): 0.86 0.1 (38 6 5), n = 14, p = 0.01;
NMDA: control: 1 6 0.1(29 6 4), GluR2(R607Q:S880E): 0.6 6
0.1(17 6 2), n = 13, p < 0.01). p values calculated with Wilcoxon
test. Scale: 20 pA, 20 ms.
Error bars indicate SEM.that recombinant GluR2(R607Q) is incorporated into
synapses (Figure 5C). In contrast, for slices exposed to
Ab peptide, neurons expressing GluR2(R607Q) showed
no significant increase in rectification compared to neu-
rons not expressing GluR2(R607Q). Therefore, Ab expo-
sure reduced recombinant GluR2 receptors at synap-
ses. We conclude that Ab overexpression decreases
surface and synaptic AMPA receptors.
AMPAR Endocytosis Required for Ab-Induced
Synaptic Depression
AMPA receptors containing GluR2 can undergo consti-
tutive cycling in and out of the synapse, which maintains
synaptic transmission constant, as well as activity-
induced removal during LTD. Ab may cause synaptic
depression by driving endocytic removal of GluR2.
Alternatively, Ab could prevent constitutive synaptic de-
livery and incorporation of GluR2. We tested whether Ab
drives AMPA receptor endocytosis by employing
a GluR2 mutant, GluR2(R845A), which blocks AP2-
dependent GluR2 endocytosis and thereby blocks LTD
(Brown et al., 2005; Lee et al., 2002). The R845A mutation
was introduced into the inwardly rectifying GFP-
GluR2(R607Q) mutant to monitor synaptic incorporation
of the recombinant receptor. When expressed alone,
GluR2(R607Q;R845A) increased the amplitude and in-
ward rectification of evoked AMPAR transmission, with-
out affecting NMDA currents, as compared to neighbor-
ing nontransfected cells. These results are consistent
with synaptic accumulation of the mutant receptor due
to decreased clathrin-dependent receptor endocytosis
that likely occurs under basal conditions (Figure 5, see
also result shown in Figures 3F and 3G). Coexpression
of GluR2(R607Q;R845A) with APP or APP(MV) also in-
creased AMPA-mediated transmission and rectification
without affecting NMDA currents (Figures 5A and 5B). In
fact, there was no difference in the AMPA-mediated
transmission or rectification when the three conditions
[GluR2(R607;R845A alone, with APP, or APP(MV)] were
compared with each other (Figures 5A and 5B). These
results indicate that Ab produced by APP overexpres-
sion induces synaptic depression by driving endocyto-
sis of AMPA type receptors. Interestingly, coexpression
of APP with GluR2(R607Q;R845A) blocked Ab-induced
depression of NMDAR mediated transmission (Fig-
ure 5B). Therefore, Ab-induced NMDA depression is de-
pendent on the endocytosis of GluR2-type AMPA recep-
tors. This is further addressed in the Discussion section.
Enhanced AMPAR Endocytosis Mimics Structural
and Functional Effects of Ab
To examine whether enhanced endocytosis of synaptic
AMPA receptors shows the same electrophysiological
and morphological effects as overexpression of APP,
we expressed a GluR2 phosphomimetic mutant
[GluR2(R607Q;S880E]). The S880 residue in GluR2 is
phosphorylated during LTD (Kim et al., 2001a), and
phosphomimetic mutations at this site enhance GluR2
endocytosis via interactions with the PDZ-containing
protein, PICK (Chung et al., 2000; Seidenman et al.,
2003). Expression of GluR2(S880E) led to the expected
decrease in AMPAR-mediated synaptic transmission
(Seidenman et al., 2003) but also to a decrease in
NMDAR-mediated synaptic transmission (Figure 6C).
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838We next examined the effects of GluR2(R607Q;S880E)
on dendritic spines. Untagged GluR2 receptors were
expressed to avoid potential morphological effects of
masking the extracellular N terminus of GluR2 (Passa-
faro et al., 2003). GluR2(R607Q;S880E) expression led
to a significant decrease in spine density compared to
expression of GluR2(R607Q) (Figures 6A and 6B). Inter-
estingly, dissociated cortical neurons exposed to 2 mM
exogenous Ab(1-42) for 5–15 min showed a small but
significant increase in phosphorylated GluR2-S880
when compared to vehicle-exposed cultures (see Fig-
ure S2). We conclude that loss of synaptic AMPA
receptors driven by Ab-induced phosphorylation of
GluR2(S880) leads to spine loss, as well as to a decrease
in NMDAR-mediated synaptic transmission.
AMPAR Endocytosis Required for Ab-Induced
Spine Loss
GluR2(R607Q;R845A), when coexpressed with APP, pre-
vents the synaptic depression induced by Ab (Figure 5). In
addition, increased GluR2 endocytosis leads to a mor-
phological change in spine density that resembles the
Ab effects (Figure 6). These results point toward the pos-
sibility that blocking GluR2 endocytosis could prevent the
morphological changes induced by Ab. As observed with
APP overexpression (Figures 1A and 1C), coexpression of
APP, GluR2(R607Q), and cytoplasmic EGFP reduces
spine density when compared to cells expressing
GluR2(R607Q) and EGFP alone (Figures 7A and 7B). Co-
expression of APP with GluR2(R607Q;R845A), however,
reveals no difference in spine density when compared
to GluR2(R607Q;R845A) expressed alone. These results
show that expression of GluR2(R607Q;R845A) blocks
APP-induced synaptic depression and APP-induced
spine loss. Thus, endocytosis and removal of synaptic
AMPA receptors is required for the structural and func-
tional changes induced by Ab. Taken together, we show
that Ab uses parts of the LTD pathway to execute its
effects on neurons.
Discussion
APP and its catabolite, Ab, play critical roles in the etiol-
ogy of Alzheimer’s disease (Selkoe and Schenk, 2003).
In addition to neuronal death, the histopathology of AD
includes significant loss of synaptic markers, synaptic
receptors, and postsynaptic spines (Carter et al., 2004;
Einstein et al., 1994; Masliah et al., 2001; Terry et al.,
1991; Thorns et al., 1997). Transgenic mouse models
of AD also display loss in synaptic markers. Further-
more, synaptic dysfunction and learning deficits in these
animals appear before amyloid plaque deposition (Hsia
et al., 1999; Moechars et al., 1999; Mucke et al., 2000;
Spires et al., 2005). Previous studies from this lab, and
others, have shown that increased Ab levels depress
glutamatergic synaptic transmission and surface recep-
tor number (Almeida et al., 2005; Cullen et al., 1997; Hsia
et al., 1999; Kamenetz et al., 2003; Oddo et al., 2003;
Snyder et al., 2005). In the present study, we examine
the mechanisms underlying Ab-induced depression of
glutamatergic synaptic transmission.Spine Loss and Synaptic Depression
Our results indicate that Ab, either formed by overex-
pression of recombinant APP or applied directly, de-
creases spine density. Spines are a major site of gluta-
matergic synapses, and thus their loss can explain our
previous observations that Ab induces glutamatergic
synaptic depression (Kamenetz et al., 2003). A decrease
in spine density has also been observed in transgenic
mouse models of AD and in brain sections from patients
with the disease (Einstein et al., 1994; Lanz et al., 2003;
Moolman et al., 2004; Spires et al., 2005; Tsai et al.,
2004). This spine loss can be produced by APP overex-
pression in organotypic slices after 3 days or incubation
with synthetic Ab(1-42) for 7 days (this study, Figure 1).
Additionally, incubation of dissociated neuronal cultures
with synthetic Ab peptides results in degradation and
loss of PSD95, a synaptic scaffolding protein (Almeida
et al., 2005; Roselli et al., 2005). Taken together, we con-
clude that Ab can cause loss of synapses that ultimately
results in behavioral deficits that occur prior to plaque
formation or cell death.
Figure 7. GluR2(R845A) Blocks Ab-Induced Loss in Spine Number
(A) Apical dendrites expressing indicated constructs (along with
EGFP) were imaged with 2PLSM. Scale: 10 mm.
(B) Coexpression of APP with GluR2(R607Q) decreases spine density
when compared to GluR2(R607Q) expression alone (spine density (sp/
mm): GluR2(R607Q): 0.65 6 0.04, 32 dendrites; APP/GluR2(R607Q):
0.51 6 0.05, 33 dendrites, 4 cells/construct, p = 0.036). When
GluR2(R607Q;R845A) is coexpressed with APP, there is no difference
in spine density when compared to GluR2(R607Q;R845A) expression
alone (spine density (sp/mm): GluR2(R607Q;R845A): 0.73 6 0.06,
27 dendrites; APP/GluR2(R607Q;R845A): 0.77 6 0.05, 29 dendrites;
4 cells/construct, p = 0.6). p values calculated with t test.
Error bars indicate SEM.
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Mechanisms
To gain more insight into the mechanisms underlying
Ab-induced depression, we tested interactions with
mGluR-dependent LTD. We observe that neurons gen-
erating increased Ab show depressed transmission
and exhibit lowered mGluR-dependent LTD. This indi-
cates a partial occlusion of LTD and suggests that Ab-
induced depression shares some mechanisms em-
ployed by LTD. This is consistent with reports showing
that Ab interacts with pathways activated by group I
mGluRs (Tyszkiewicz and Yan, 2005; Wang et al.,
2004) and can facilitate LTD induction in vivo (Kim
et al., 2001b). Recently, Chang et al. have demonstrated
that aged double knockin mice also exhibit deficits in
LTD induction (Chang et al., 2006). LTD requires both
calcineurin and p38 MAP kinase activity (Bolshakov
et al., 2000; Brown et al., 2005; Mulkey et al., 1994;
Rush et al., 2002; Zhu et al., 2002). We now report that
Ab-induced synaptic depression is blocked by drugs
that inhibit these enzymes. Calcineurin activity is also re-
quired for Ab-induced reductions in NMDA receptor
function in dissociated cultured neurons (Snyder et al.,
2005), consistent with our findings. And last, we find
that Ab application leads to phosphorylation of GluR2
at a site important for LTD. In cerebellar LTD this
GluR2 residue appears to be phosphorylated by PKC
(Xia et al., 2000), while in the hippocampus, the respon-
sible kinase has not been identified (Kim et al., 2001a).
We conclude that Ab-induced synaptic depression
uses second messenger pathways that likely depress
synaptic transmission under physiological conditions.
AMPA Receptor Endocytosis Mediates Ab-Induced
Synaptic Effects
The expression of LTD is believed to result from endo-
cytic removal of synaptic AMPA receptors (Carroll
et al., 1999; Lin et al., 2000; Man et al., 2000; Snyder
et al., 2001; Xiao et al., 2001) . Using ‘‘electrophysiologi-
cal tagging’’ of GluR2 (Shi et al., 2001) we find that Ab
reduces synaptic AMPA receptors. These results are
further supported by our imaging studies using a SEP-
tagged AMPA receptor (Ashby et al., 2004; Kopec
et al., 2006; Miesenbock et al., 1998) in which we demon-
strate that increased Ab expression reduces AMPARs on
the surface of spines. These results are consistent with
studies showing that bath application of Ab induces en-
docytosis of surface GluR1 and NMDAR in dissociated
cultured neurons and that cultured neurons from
Alzheimer’s disease mouse models also show reduced
surface GluR1 and NMDARs (Almeida et al., 2005;
Snyder et al., 2005). Our synaptic tagging experiments
demonstrate that not only surface but indeed synaptic
receptors are lost in conditions with increased Ab. This
finding is important since there can be loss of surface
receptors with little effect on synaptic transmission
(e.g., GluR1 KO animals have dramatic loss of extra-
synaptic surface receptors but synaptic transmission is
intact (Zamanillo et al., 1999). Interestingly, increased
Ab also decreased SEP-tagged GluR1 and GluR2 from
dendritic surface regions, suggesting that synaptic
AMPARs may be in equilibrium with a pool of dendritic
surface receptors.The removal of receptors during LTD uses clathrin-me-
diated endocytosis that requires AP2 interactions and
dynamin (Lee et al., 2002; Luscher et al., 1999). A muta-
tion (R845A) introduced in the cytoplasmic terminus of
GluR2 weakens AP2 interactions and inhibits LTD
(Brown et al., 2005; Lee et al., 2002). We demonstrate
that this GluR2 mutant blocks the synaptic depression
produced by increased Abproduction, a finding that pro-
vides strong support for the view that Ab-induced de-
pression of AMPAR-mediated transmission is the result
of endocytosis of AMPA receptors. GluR2(R845A) also
prevents APP-induced reduction of NMDAR-mediated
transmission. Recent studies have shown that incuba-
tion of dissociated cultured neurons with synthetic Ab
enhances NMDA receptor endocytosis via calcineurin
and striatal enriched phosphatase (STEP) activity
(Snyder et al., 2005). Our results indicate that Ab-
mediated endocytosis of NMDA receptors requires en-
docytosis of GluR2-containing AMPA receptors. Indeed,
expression of a mutant GluR2 that promotes its endo-
cytosis led to decreased AMPA- as well as NMDA-
mediated synaptic responses.
How could synaptic loss of AMPA receptors lead to
loss of synaptic NMDA receptors? Electron microscopic
studies show a positive correlation between spine size,
synapse size, and synaptic AMPA receptor number
(Harris et al., 1992; Nusser et al., 1998; Takumi et al.,
1999). Furthermore, small spines have shorter lifetimes
than larger spines in chronic in vivo imaging studies
(Holtmaat et al., 2005; Zuo et al., 2005). Thus, one may
hypothesize that AMPA receptors (and especially
GluR2, see Passafaro et al., 2003) stabilize synaptic
spines and that removal of AMPA receptors could lead
to spine elimination. Loss of spines may include endocy-
tosis of synaptic NMDA receptors, which could explain
the effects seen by Snyder et al. (2005). Our results,
showing that expression of a phosphomimetic mutant
AMPAR that drives its endocytosis leads to loss of
spines, further support the hypothesis that AMPARs
stabilize spines. With this view, Ab induces endocytosis
of AMPA receptors, which then causes loss of spines
and NMDA responses. Most importantly, we find that
blocking the Ab-induced removal of AMPA receptors
prevents a reduction in spine number and blocks the de-
crease in NMDAR response. In conclusion, our results
indicate that Ab drives the removal of synaptic AMPA re-
ceptors and this plays a key role in the toxic effects of Ab
on spines. In the future, strategies that target stabiliza-
tion of synaptic AMPARs may prove useful in the treat-
ment of Alzheimer’s disease.
Experimental Procedures
DNA Constructs
Virally expressed human APP695, b-CTF, and APP(MV) were co-
expressed with EGFP using an internal ribosomal entry site (IRES)
construct as described (Hayashi et al., 2000; Kamenetz et al.,
2003). The GFP-GluR1, GFP-GluR2(R607Q), SEP-GluR1, and SEP-
GluR2(R607Q) constructs were described previously (Kopec et al.,
2006; Shi et al., 2001). The R845A and S880E mutations were intro-
duced into GFP-GluR2(R607Q) using the QuickChange system
(Stratagene). Untagged GluR2 constructs were generated from
GFP-tagged constructs by cutting out the GFP with NheI and ApaI
and religating the plasmid. All electrophysiology was performed
with GFP-tagged receptors, while untagged receptors were used
in imaging experiments (Figures 6 and 7). The tDimer dsRed
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840(provided by R. Tsien) and EGFP (Clontech) were used as cytoplas-
mic markers. For biolistic transfection, constructs were subcloned
into the pCI expression vector (Promega).
Hippocampal Slice Cultures, Transfection, and Sindbis
Pseudoviruses Infection
Organotypic hippocampal slice cultures were made from postnatal
day 6 or 7 rat pups as described (Stoppini et al., 1991). Slice cultures
were maintained in culture for 6–9 days, then transfected using either
Sindbis virus (Invitrogen) or biolistic GeneGun transfection (BioRad).
Cells were recorded 22–26 hr after Sindbis virus infection, whereas
biolistically transfected neurons were recorded/imaged 3–4 days
after transfection. Cells in Ab application experiment were imaged
7 days after transfection. Sindbis pseudovirus was prepared as
described previously (Hayashi et al., 2000). Biolistic transfection
was used to coexpress multiple constructs. For GeneGun bullets,
constructs were used in a 1:1 molar ratio except for cytoplasmic
marker plasmids, which were used in 1:8 (EGFP) or a 1:4 (tDimer)
ratio to other constructs. For control conditions (i.e., Figure 1A,
EGFP control), empty pCI vector was used in lieu of APP or APP(MV).
Dissociated Cortical Cultures and Immunoblot
for Phospho-GluR2
Dissociated cortical cultures were prepared from embryonic day 18
old rats. In short, the cortices were dissected, digested in Papain
(Sigma), titurated to isolate cells, and plated with a density of 2 3
105 cells per well on previously poly-D-lysine (Sigma) coated 6-well
plates. After 2 weeks in culture, freshly prepared Ab (see below) or
vehicle (5% NH4OH, 0.05 M Tris [pH 7.5]) was added to the medium
and the cells were incubated for 5–15 min. The neurons were washed
and harvested with ice-cold buffer (in mM: 167 NaCl, 5.4 KCl, 11 glu-
cose, 1.8 CaCl2, and 10 HEPES [pH7.3], 320 mOsm). Lysis took place
in 1% SDS, the cells were first sonicated and afterwards boiled at
100C for 10 min. Per lane, 10 mg of protein were analyzed by immu-
noblot with an anti-phospho-GluR2(Ser880) antibody (Upstate)
followed by stripping the blot and reprobing it with an anti-GluR2 an-
tibody (Chemicon) as loading control. The signal for phosphoGluR2
was normalized against total GluR2 in vehicle and Ab-treated
cultures. Both groups were compared with the Wilcoxon test.
Image Acquisition and Quantification
Images were collected using a custom-built two-photon microscope
and analyzed using custom software described before (Kopec et al.,
2006). CA1 pyramidal cells were identified with epifluorescence.
Typically, one to two CA1 cells were transfected per slice and ana-
lyzed. Cell soma and w200 mm apical dendrites, starting 50 mm
from the soma, were imaged and were analyzed blind to the experi-
mental protocol. Because of optical constraints, spines emerging
above or below the dendrite were not analyzed. Spine density was
the number of manually counted spines divided by dendrite segment
length. Spine density values are compared across conditions with an
unpaired two-tailed Student’s t test. Significance was set at p < 0.05.
To measure the content of tDimer or SEP-tagged receptor in
a spine, a 103 10 pixel (box) region of interest was drawn to encom-
pass a spine or dendritic region. Fluorescence signal was defined as
signal greater than three standard deviations above background.
Signal was background subtracted, and leak from one channel to
the other was corrected by independent measurements of tDimer
or EGFP (leak values: red / green w0.15; green / red w0.01).
Structures were identified in the red channel with z boundaries de-
fined by the full-width at half-max of fluorescence signal; the red
and green signals were integrated over this volume. Red signal
was normalized for level of expression by dividing the integrated
red signal (Rint) of a structure by the peak red signal measured in
a 10 3 10 pixel (box) region of interest in the cell soma (Rmax).
The green signal (Gint) in spines and dendrites was not normalized
by soma green signal (Gmax) since the amount of recombinant
receptor in spines is not dependent on recombinant receptor
expression levels (see Figure S1). Dendrite expression of recombi-
nant receptors is independent of soma overexpression levels (Kes-
sels et al., personal communication). The green/normalized red ratio
was calculated by dividing the spine or dendrite integrated green
signal (Gint) by the normalized spine or dendrite integrated red sig-nal (Rint/Rmax). Data were compared using an unpaired two-tailed
Student’s t test.
To determine whether Sindbis overexpression of EGFP, APP, or
APP(MV) ov affects endogenous GluR1 and GluR2 levels, immuno-
histochemistry was performed on slices infected for 22–26 hr with
either EGFP, APP IRES EGFP, or APP(MV) IRES EGFP. Slices were
fixed at 4C in 4% paraformaldehyde/4% sucrose for 1 hr, washed
in PBS, then permeabilized for 45 min in 0.3% Triton-PBS at 4C.
After washing and blocking in 10% horse serum PBS, slices were
incubated overnight (4C) in primary anti-GluR1 or anti-GluR2
(Chemicon). Texas Red conjugated secondary antibodies (Molecular
Probes) were used to visualize labeled structures. Somas were
imaged using 2PLSM with the imaging conditions described above.
Leak values were calculated for Texas Red (red/green 0.005). Three
contiguous z stacks were collapsed and leak subtracted (green and
red) for analysis. Ten-pixel-wide profiles were drawn over somas
where the apical dendrite originates, and the peak red signal was
measured. Sindbis-infected neurons were identified in the green
channel. The red signal in the Sindbis-infected neurons was normal-
ized to the red signals of uninfected neurons within the same image.
Data were compared using an unpaired two-tailed Student’s t test.
Electrophysiology and Pharmacological Treatments
Rectification and simultaneous whole-cell recordings were obtained
from pairs of neighboring (<50 mm) control and infected/transfected
CA1 pyramidal neurons as described before (Kamenetz et al., 2003;
Kopec et al., 2006). For mGluR LTD experiments, 130 mM potassium
gluconate and 5 mM KCl were substituted for cesium methansulfo-
nate and CsCl in the internal solution. All recordings were done by
stimulating two independent synaptic inputs; results from each
pathway were averaged and counted as n = 1.
For pharmacological experiments, drugs were added to media
before transfection, maintained every 12 hr, and included in ACSF
during recordings. Treatments used: 2 mM SB203580 (vehicle: water,
Calbiochem), 50 mM FK506 (vehicle: DMSO, Fujisawa), 2 mM L-685-
458 (vehicle: DMSO, Merck), 5 mM SP600125 (vehicle: DMSO,
Calbiochem). mGluR LTD was induced by 5 min bath application
of 100 mM (R,S)-3,5-dihydroxyphenylglycine (DHPG) (vehicle: water,
Tocris). The cell was held in current clamp during DHPG application
and 5 min afterwards (Huber et al., 2001).
For mEPSC studies, drugs were applied to slice cultures at 7 DIV
and recordings were performed at 8 DIV. One mM TTX (vehicle:
water, Sigma) was included in ACSF to block sodium channels.
The same ACSF was used as described above, except Ca+2 and
Mg+2 concentrations were changed to 2.5 mM and 1.2 mM, respec-
tively. Data were acquired at 5 kHz, filtered at 2 kHz, and analyzed
with template matching using Axograph (Axon instruments) with
the following mEPSC criteria: 5 ms baseline, event length 30 ms,
rise time 0.2–5 ms, decay t < 7 ms, threshold = 3* standard deviation
of noise. Average mEPSC amplitude and interevent interval were
calculated for each cell.
All data are reported as mean 6 SEM. Statistical analysis for
paired recordings used the Wilcoxon test. To compare rectification
values across constructs, the rectification of transfected cells were
normalized by the mean control cell rectification, then tested across
groups using an unpaired two-tailed Student’s t test. For LTD exper-
iments, the Wilcoxon test was used for pairwise comparisons, while
the Student’s t test was used to compare magnitude of LTD induc-
tion. Drug conditions for mEPSC recordings were compared using
a two-taileded Student’s t test. Significance was set at p < 0.05.
Ab Peptides
Peptides (Biosource, CA) were dissolved in vehicle and sonicated,
then aliquoted and stored at 280C. One mM Ab(1-42) or Ab(42-1)
or vehicle (dependent on the manufacturer’s instructions 0.2%
DMSO or 5% NH4OH in Tris buffer) was included in the media of
EGFP-transfected 7 DIV slice cultures and were maintained every
2–3 days for a week. There was no statistical difference in spine den-
sity between the Ab(42-1) and vehicle condition, so the data were
pooled and considered as a control group.
Quantification of Ab Secretion by Two-Site ELISAs
Organotypic hippocampal slice cultures were prepared from 6- to
7-day-old APPSwe transgenic mice (Borchelt et al., 1997) and
AMPAR Endocytosis Underlies Ab-Induced Spine Loss
841cultured for 7 days. Five slices were placed on each membrane. Sli-
ces were maintained with or without drugs for 4 days whereupon
slice culture media was collected and mixed with 0.075% CHAPS
and 0.2% BSA to prevent protein precipitation. Ab was measured
using a two-site ELISA that specifically detects the C terminus of
Ab, as described (Tomita et al., 1997).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/5/831/DC1/.
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